15 June 2020 : Clinical Research
Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis
Sikai Nong1BCD, Xinbin Pan1BCD, Kaihua Chen1EF, Ye Li1CD, Xiaodong Zhu1AFG*DOI: 10.12659/MSM.922244
Med Sci Monit 2020; 26:e922244
Table 6 Independent prognostic factors from multivariate analysis for overall survival.
| Factors | HR | 95% CI for HR | P-value |
|---|---|---|---|
| Number of bone metastatic sites (<3 ≥3) | 1.513 | (1.076~2.129) | 0.017 |
| Chemotherapy cycles (<6 ≥6) | 0.462 | (0.237–0.899) | 0.023 |